RU2001124802A - The use of saredutant and its pharmaceutically acceptable salts for the preparation of medicines used to treat or prevent mood disorders, adaptation disorders or mixed anxiety-depressive disorders - Google Patents
The use of saredutant and its pharmaceutically acceptable salts for the preparation of medicines used to treat or prevent mood disorders, adaptation disorders or mixed anxiety-depressive disordersInfo
- Publication number
- RU2001124802A RU2001124802A RU2001124802/14A RU2001124802A RU2001124802A RU 2001124802 A RU2001124802 A RU 2001124802A RU 2001124802/14 A RU2001124802/14 A RU 2001124802/14A RU 2001124802 A RU2001124802 A RU 2001124802A RU 2001124802 A RU2001124802 A RU 2001124802A
- Authority
- RU
- Russia
- Prior art keywords
- disorders
- saredutant
- preparation
- pharmaceutically acceptable
- adaptation
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title claims 6
- 230000004301 light adaptation Effects 0.000 title claims 3
- 201000008895 mood disease Diseases 0.000 title claims 3
- PGKXDIMONUAMFR-AREMUKBSSA-N Saredutant Chemical compound C([C@H](CN(C)C(=O)C=1C=CC=CC=1)C=1C=C(Cl)C(Cl)=CC=1)CN(CC1)CCC1(NC(C)=O)C1=CC=CC=C1 PGKXDIMONUAMFR-AREMUKBSSA-N 0.000 title claims 2
- 229950004387 Saredutant Drugs 0.000 title claims 2
- 150000003839 salts Chemical class 0.000 title claims 2
- 239000011780 sodium chloride Substances 0.000 title claims 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 claims 7
- 206010004938 Bipolar disease Diseases 0.000 claims 1
- 206010013982 Dysthymic disease Diseases 0.000 claims 1
- 201000003895 major depressive disease Diseases 0.000 claims 1
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905338A FR2792835B3 (en) | 1999-04-27 | 1999-04-27 | USE OF SAREDUTANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OR PREVENTION OF ALL MOOD DISORDERS, ADAPTATION DISORDERS OR MIXED ANXIETY-DEPRESSION DISORDERS |
FR99/05,338 | 1999-04-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001124802A true RU2001124802A (en) | 2003-06-20 |
RU2238726C2 RU2238726C2 (en) | 2004-10-27 |
Family
ID=9544931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001124802/14A RU2238726C2 (en) | 1999-04-27 | 2000-04-25 | Employment of saredutant and pharmaceutically acceptable salts thereof for preparing therapeutic products useful in treatment and prevention of extensive depressive disorders |
Country Status (33)
Country | Link |
---|---|
US (3) | US6573281B1 (en) |
EP (1) | EP1173179B1 (en) |
JP (1) | JP2002542281A (en) |
KR (1) | KR20020001850A (en) |
CN (1) | CN1172669C (en) |
AR (1) | AR023597A1 (en) |
AT (1) | ATE234617T1 (en) |
AU (1) | AU764304B2 (en) |
BG (1) | BG65472B1 (en) |
BR (1) | BR0010006A (en) |
CA (1) | CA2370834C (en) |
CZ (1) | CZ294904B6 (en) |
DE (1) | DE60001725T2 (en) |
DK (1) | DK1173179T3 (en) |
EE (1) | EE05211B1 (en) |
ES (1) | ES2193065T3 (en) |
FR (1) | FR2792835B3 (en) |
HK (1) | HK1041821A1 (en) |
HU (1) | HUP0200969A3 (en) |
IL (1) | IL145269A0 (en) |
MX (1) | MXPA01010904A (en) |
NO (1) | NO20015228L (en) |
NZ (1) | NZ513851A (en) |
PL (1) | PL196479B1 (en) |
PT (1) | PT1173179E (en) |
RU (1) | RU2238726C2 (en) |
SI (1) | SI1173179T1 (en) |
SK (1) | SK285459B6 (en) |
TR (1) | TR200102512T2 (en) |
TW (1) | TWI225399B (en) |
UA (1) | UA69441C2 (en) |
WO (1) | WO2000064423A2 (en) |
ZA (1) | ZA200107143B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2792835B3 (en) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | USE OF SAREDUTANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OR PREVENTION OF ALL MOOD DISORDERS, ADAPTATION DISORDERS OR MIXED ANXIETY-DEPRESSION DISORDERS |
US6846814B2 (en) | 2000-04-06 | 2005-01-25 | Astra Zeneca Ab | Neurokinin antagonists for use as medicaments |
WO2001077089A1 (en) * | 2000-04-06 | 2001-10-18 | Astrazeneca Ab | New neurokinin antagonists for use as medicaments |
US6903092B2 (en) | 2000-04-06 | 2005-06-07 | Peter Bernstein | Naphthamide neurokinin antagonists for use as medicaments |
WO2001077069A1 (en) * | 2000-04-06 | 2001-10-18 | Astrazeneca Ab | Naphthamide neurokinin antagonists for use as medicaments |
GB0019008D0 (en) * | 2000-08-04 | 2000-09-27 | Astrazeneca Ab | Therapeutic compounds |
SE0003476D0 (en) * | 2000-09-28 | 2000-09-28 | Astrazeneca Ab | Compounds |
FR2912057B1 (en) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | PHARMACEUTICAL COMPOSITION COMPRISING SAREDUTANT AND A SELECTIVE SEROTONIN RECAPTURE INHIBITOR OR SEROTONIN / NOREPINEPHRINE RECAPTURE INHIBITOR |
FR2904221B1 (en) * | 2006-07-31 | 2008-09-12 | Sanofi Aventis Sa | PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION SAREDUTANT AND FLUOXETINE. |
TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
FR2912058A1 (en) * | 2007-02-07 | 2008-08-08 | Sanofi Aventis Sa | Treatment or prevention of sexual dysfunction, e.g. lack of sexual desire or erectile dysfunction, uses neurokinin A NK2 receptor antagonist, e.g. sareductant |
KR101174980B1 (en) * | 2007-09-14 | 2012-08-17 | 에프. 호프만-라 로슈 아게 | piperidine derivatives as NK3 receptor antagonists |
US20090076083A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched saredutant |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
FR2695626B1 (en) * | 1992-09-17 | 1994-12-02 | Lebroch Yannick | Cup device adaptable to a beverage container. |
FR2700472B1 (en) | 1993-01-19 | 1995-02-17 | Rhone Poulenc Rorer Sa | Synergizing association having an antagonistic effect on the NK1 and NK2 receptors. |
US5512680A (en) * | 1993-02-26 | 1996-04-30 | Sanofi | Process for the preparation of an optically pure aminoalcohol |
TW385308B (en) * | 1994-03-04 | 2000-03-21 | Merck & Co Inc | Prodrugs of morpholine tachykinin receptor antagonists |
US5554644A (en) * | 1994-06-08 | 1996-09-10 | Warner-Lambert Company | Tachykinin (NK2) antagonists |
FR2792835B3 (en) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | USE OF SAREDUTANT FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OR PREVENTION OF ALL MOOD DISORDERS, ADAPTATION DISORDERS OR MIXED ANXIETY-DEPRESSION DISORDERS |
-
1999
- 1999-04-27 FR FR9905338A patent/FR2792835B3/en not_active Expired - Fee Related
-
2000
- 2000-04-25 HU HU0200969A patent/HUP0200969A3/en unknown
- 2000-04-25 EP EP00922735A patent/EP1173179B1/en not_active Expired - Lifetime
- 2000-04-25 TR TR2001/02512T patent/TR200102512T2/en unknown
- 2000-04-25 IL IL14526900A patent/IL145269A0/en not_active IP Right Cessation
- 2000-04-25 DE DE60001725T patent/DE60001725T2/en not_active Expired - Lifetime
- 2000-04-25 US US09/958,439 patent/US6573281B1/en not_active Expired - Fee Related
- 2000-04-25 KR KR1020017013704A patent/KR20020001850A/en not_active Application Discontinuation
- 2000-04-25 DK DK00922735T patent/DK1173179T3/en active
- 2000-04-25 WO PCT/FR2000/001084 patent/WO2000064423A2/en not_active Application Discontinuation
- 2000-04-25 NZ NZ513851A patent/NZ513851A/en not_active IP Right Cessation
- 2000-04-25 SI SI200030071T patent/SI1173179T1/en unknown
- 2000-04-25 EE EEP200100553A patent/EE05211B1/en not_active IP Right Cessation
- 2000-04-25 BR BR0010006-4A patent/BR0010006A/en not_active Application Discontinuation
- 2000-04-25 RU RU2001124802/14A patent/RU2238726C2/en not_active IP Right Cessation
- 2000-04-25 CN CNB008066817A patent/CN1172669C/en not_active Expired - Fee Related
- 2000-04-25 ES ES00922735T patent/ES2193065T3/en not_active Expired - Lifetime
- 2000-04-25 CA CA002370834A patent/CA2370834C/en not_active Expired - Fee Related
- 2000-04-25 MX MXPA01010904A patent/MXPA01010904A/en active IP Right Grant
- 2000-04-25 SK SK1547-2001A patent/SK285459B6/en not_active IP Right Cessation
- 2000-04-25 AT AT00922735T patent/ATE234617T1/en active
- 2000-04-25 JP JP2000613414A patent/JP2002542281A/en active Pending
- 2000-04-25 CZ CZ20013812A patent/CZ294904B6/en not_active IP Right Cessation
- 2000-04-25 AU AU43034/00A patent/AU764304B2/en not_active Ceased
- 2000-04-25 PT PT00922735T patent/PT1173179E/en unknown
- 2000-04-25 PL PL351922A patent/PL196479B1/en not_active IP Right Cessation
- 2000-04-25 UA UA2001096123A patent/UA69441C2/en unknown
- 2000-04-26 AR ARP000101955A patent/AR023597A1/en unknown
- 2000-05-10 TW TW089107876A patent/TWI225399B/en not_active IP Right Cessation
-
2001
- 2001-08-29 ZA ZA200107143A patent/ZA200107143B/en unknown
- 2001-09-28 BG BG105962A patent/BG65472B1/en unknown
- 2001-10-25 NO NO20015228A patent/NO20015228L/en not_active Application Discontinuation
-
2002
- 2002-05-14 HK HK02103636A patent/HK1041821A1/en not_active IP Right Cessation
-
2003
- 2003-04-08 US US10/409,504 patent/US7390823B2/en not_active Expired - Fee Related
-
2008
- 2008-05-21 US US12/124,262 patent/US20080227818A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9700603A1 (en) | Pharmaceutical preparation for the treatment of blood coagulation disorders | |
ATE142877T1 (en) | MELATONINE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS AND FOR PRE-ANESTHESIA | |
DE60020613D1 (en) | (S, S) reboxetine for the treatment of fibromyalgia and other somatoform disorders | |
IL143512A (en) | Azabicycloalkanes, pharmaceutical compositions comprising same and use thereof for the manufacture of medicaments for the prevention or treatment of infection by immunodeficiency virus | |
ATE399553T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES | |
ATE269846T1 (en) | N-SUBSTITUTED AMINOTETRALINES AS NEUROPEPTIDE Y Y5 RECEPTOR LIGANDS AND THEIR USE IN THE TREATMENT OF OBESITY AND OTHER DISEASES | |
RU2001124802A (en) | The use of saredutant and its pharmaceutically acceptable salts for the preparation of medicines used to treat or prevent mood disorders, adaptation disorders or mixed anxiety-depressive disorders | |
DE60132851D1 (en) | Medicines for the prevention, alleviation or treatment of hypertension | |
DE60322075D1 (en) | PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | |
EE05211B1 (en) | Use of saredutant and its pharmaceutically acceptable salts in the preparation of medicaments useful for the treatment or prevention of mood disorders, adaptive disorders, or mixed depressive disorders. | |
DE69939075D1 (en) | Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus | |
MX9707642A (en) | Pharmaceutical agents for the treatment of alzheimer's disease. | |
PT888114E (en) | USING (+) - ALPHA- (2,3-DIMETOXYPHENYL) -1- [2- (4-FLUOROPHENYL) ETHYL] -4-PIPERIDINOMETHANOL IN THE TREATMENT OF DEPRESSIVE DISEASES AND BIPOLAR DISEASES | |
ATE228843T1 (en) | USE OF DESOXYPEGANINE TO TREAT DRUG DEPENDENCE | |
BG105984A (en) | Osanetant in the treatment of mood disorders | |
DE60107900D1 (en) | Pharmaceutical composition and food for the treatment of cerebral edema | |
DE60306503D1 (en) | STATIN THERAPY FOR IMPROVING THE MAINTENANCE OF COGNITIVE FUNCTION | |
ATE195876T1 (en) | PURIFICATION OF A SUBSTANCE INHIBITING MÜLLER'S MIXED TUMOR AND TREATMENT OF SOME TUMORS | |
DE69732492D1 (en) | USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEAVY DEPRESSIONS ACCOMPANIED BY ANXIETY STATES | |
HUT71422A (en) | Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases | |
EA200200656A1 (en) | NEW THERAPEUTIC COMBINATIONS (S) -2- (BENZYLAMINOMETYL) -2,3,8,9-TETRAHYDRO-7H-1,4-DIOXIN [2,3-th] INDOL-8-SHE AND NEUROLEPTIC FOR TREATMENT OR PREVENTION OF PSYCHOLOGICAL | |
RU2001119471A (en) | USE OF RILUZOL IN THE TREATMENT OF ACOUSTIC INJURIES | |
RU2001127309A (en) | The use of osanetant in the manufacture of drugs useful for the treatment of mood disorders | |
BR9913242A (en) | Use of r (+) - alpha- (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-p iperidinamethanol for the treatment of sleep disorders | |
RU99104703A (en) | METHOD FOR TREATING LOWER JAW OSTEOMYELITIS |